Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
journalStr:"Breast cancer research and treatment"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (123)
1
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting : final analysis of LUCY
enthalten in:
Breast cancer research and treatment
| 2024
von
Balmaña, J.
|
Fasching, P.
|
Couch, F.
| +123
Wird geladen...
2
Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)
enthalten in:
Breast cancer research and treatment
| 2023
von
Hwang, I.
|
Kim, J.
|
Jeong, J.
| +8
Wird geladen...
3
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
enthalten in:
Breast cancer research and treatment
| 2023
von
Iwata, H.
|
Yamamoto, Y.
|
Sakai, T.
| +12
Wird geladen...
4
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN) : final analysis of a phase III, randomized, double-blind, placebo-controlled study
enthalten in:
Breast cancer research and treatment
| 2023
von
Xu, B.
|
Li, W.
|
Zhang, Q.
| +11
Wird geladen...
5
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer : subgroup analysis of the phase IIIb CompLEEment-1 trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Campone, M.
|
De Laurentiis, M.
|
Zamagni, C.
| +8
Wird geladen...
6
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer : primary results from cohort B of the IPATunity130 randomized phase 3 trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Turner, N.
|
Dent, R.
|
O'Shaughnessy, J.
| +13
Wird geladen...
7
Analysis of the pan-Asian subgroup of patients in the NALA Trial : a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
enthalten in:
Breast cancer research and treatment
| 2021
von
Dai, M.
|
Feng, Y.
|
Chen, S.
| +23
Wird geladen...
8
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
enthalten in:
Breast cancer research and treatment
| 2021
von
De Laurentiis, M.
|
Borstnar, S.
|
Campone, M.
| +15
ErratumIn: Breast Cancer Res Treat. 2021 Oct 8;:. - PMID 34625861
Wird geladen...
9
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer : final results from a randomized phase III trial
enthalten in:
Breast cancer research and treatment
| 2021
von
Stebbing, J.
|
Baranau, Y.
|
Baryash, V.
| +11
Wird geladen...
10
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer : Final analysis of MetaPHER, a phase IIIb single-arm safety study
enthalten in:
Breast cancer research and treatment
| 2021
von
Kuemmel, S.
|
Tondini, C.
|
Abraham, J.
| +13
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Zeitschrift: Breast cancer research and treatment
Medienart
123
Aufsätze
123
E-Artikel
E-Ressourcen
Zeitschriftentitel
Breast cancer research and treatment
Thema
123
Clinical Trial, Phase III
123
Journal Article
105
Randomized Controlled Trial
56
Research Support, Non-U.S. Gov't
53
Multicenter Study
41
EC 2.7.10.1
40
Receptor, ErbB-2
30
Breast cancer
24
Receptors, Estrogen
23
ERBB2 protein, human
21
Letrozole
20
7LKK855W8I
20
Fluorouracil
20
Taxoids
20
U3P01618RT
19
15H5577CQD
19
Antineoplastic Agents, Hormonal
19
Docetaxel
19
P188ANX8CK
19
Trastuzumab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
23
2020-
89
2010-2019
11
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
123
Englisch
Haven't found what you're looking for?
Wird geladen...